BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2232625)

  • 21. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P; Rost R; Reinke A; Nagel N; Merten U
    Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of penbutolol on glomerular filtration.
    Meyer BH; Müller FO; Lötter MG; Iturralde MP; Grigoleit HG
    S Afr Med J; 1981 Aug; 60(6):243-4. PubMed ID: 7020108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects.
    Purdon C; Brousson M; Nyveen SL; Miles PD; Halter JB; Vranic M; Marliss EB
    J Clin Endocrinol Metab; 1993 Mar; 76(3):566-73. PubMed ID: 8445012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM).
    Ratzmann KP; Schneider U; Besch W; Heinke P
    Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of dietary fat on blood sugar levels and insulin consumption after intake of various carbohydrate carriers in type I diabetics on the artificial pancreas].
    Wakhloo AK; Beyer J; Diederich C; Schulz G
    Dtsch Med Wochenschr; 1984 Oct; 109(42):1589-94. PubMed ID: 6386412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.
    Kolterman OG; Gottlieb A; Moyses C; Colburn W
    Diabetes Care; 1995 Aug; 18(8):1179-82. PubMed ID: 7587855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-exercise blood glucose affects glycemic variation of aerobic exercise in patients with type 2 diabetes treated with continuous subcutaneous insulin infusion.
    Hu Y; Zhang DF; Dai L; Li Z; Li HQ; Li FF; Liu BL; Sun XJ; Ye L; He K; Ma JH
    Diabetes Res Clin Pract; 2018 Jul; 141():98-105. PubMed ID: 29730390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
    Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
    Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meal intolerance in type 1 diabetes mellitus: influence of time interval between insulin therapy and meal intake.
    MacGillivray MH; Mills BJ; Voorhess ML
    J Med; 1984; 15(5-6):417-35. PubMed ID: 6399521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and divided doses of penbutolol.
    Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modification of myocardial function parameters by L- and D-penbutolol--an echocardiography, placebo-controlled double-blind study].
    Grube E; Herzog H; Lüderitz B
    Z Kardiol; 1985 Feb; 74(2):99-105. PubMed ID: 3993154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin, gastrointestinal and stress hormones in response to exercise in fasted or fed subjects and before or after blood donation.
    Sliwowski Z; Lorens K; Konturek SJ; Bielanski W; Zoładź JA
    J Physiol Pharmacol; 2001 Mar; 52(1):53-70. PubMed ID: 11321513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Temporal relationship between food intake, administration of insulin and physical loading in type I diabetics treated with an intensified insulin regimen].
    Rusavý Z; Lacigová S; Srámek V; Novák I; Tĕsínský P
    Cas Lek Cesk; 1995 May; 134(9):270-2. PubMed ID: 7758086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
    Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
    J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal and metabolic profiles in insulin-dependent diabetics under subcutaneous conventional and artificial endocrine pancreas (glucose continuous insulin infusion system Biostator) treatment.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Bellomo G; Antonella MA; Angeletti G; Massi-Benedetti M; Brunetti P
    J Endocrinol Invest; 1983 Feb; 6(1):1-8. PubMed ID: 6341441
    [No Abstract]   [Full Text] [Related]  

  • 37. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes.
    Bussau VA; Ferreira LD; Jones TW; Fournier PA
    Diabetes Care; 2006 Mar; 29(3):601-6. PubMed ID: 16505513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
    Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.